BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 33995638)

  • 1. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments.
    Zhu H; Wang G; Zhu H; Xu A
    J Cancer; 2021; 12(12):3611-3625. PubMed ID: 33995638
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
    Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
    J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
    [No Abstract]   [Full Text] [Related]  

  • 3. Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer.
    Li L; Huang S; Yao Y; Chen J; Li J; Xiang X; Deng J; Xiong J
    World J Surg Oncol; 2020 Dec; 18(1):324. PubMed ID: 33292276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value and Potential Mechanism of MTFR2 in Lung Adenocarcinoma.
    Lian Z; Pang P; Zhu Y; Du W; Zhou J
    Front Oncol; 2022; 12():832517. PubMed ID: 35600359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTFR2-dependent mitochondrial fission promotes HCC progression.
    Zhang L; Zhang X; Liu H; Yang C; Yu J; Zhao W; Guo J; Zhou B; Jiang N
    J Transl Med; 2024 Jan; 22(1):73. PubMed ID: 38238834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Liu B; Xiao X; Lin Z; Lou Y; Zhao L
    Cancer Biomark; 2022; 34(2):251-264. PubMed ID: 34958001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated pan-cancer analysis and experimental verification of the roles of tropomyosin 4 in gastric cancer.
    Guo Q; Zhao L; Yan N; Li Y; Guo C; Dang S; Shen X; Han J; Luo Y
    Front Immunol; 2023; 14():1148056. PubMed ID: 36993958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of the biological function and immune infiltration of SLC38A2 in gastric cancer.
    Zhu L; Wang Z; Han W; Xu A
    BMC Gastroenterol; 2023 Mar; 23(1):74. PubMed ID: 36918802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Gastric Cancer Stem Cell (GCSC) Markers Are Prognostic Factors Correlated With Immune Infiltration of Gastric Cancer.
    Lin T; Peng W; Mai P; Zhang E; Peng L
    Front Mol Biosci; 2021; 8():626966. PubMed ID: 34113647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of Immune Implications and Prognostic Value of SPI1 in Gastric Cancer.
    Huang J; Chen W; Jie Z; Jiang M
    Front Oncol; 2022; 12():820568. PubMed ID: 35237521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Hou W; Kong L; Hou Z; Ji H
    BMC Med Genomics; 2022 Oct; 15(1):225. PubMed ID: 36316684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells.
    Lu G; Lai Y; Wang T; Lin W; Lu J; Ma Y; Chen Y; Ma H; Liu R; Li J
    Aging (Albany NY); 2019 Nov; 11(22):10203-10219. PubMed ID: 31740625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Li D; Chen B; Zeng Y; Wang H
    Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors.
    Zhu H; Wang G; Zhu H; Xu A
    BMC Cancer; 2021 Mar; 21(1):269. PubMed ID: 33711961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NRSN2 is a Prognostic Biomarker in Gastric Cancer and Facilitates the Growth and Migration of Gastric Cancer Cells.
    Ren S; Chen M; Chen Y; Ding K
    Protein Pept Lett; 2023; 30(5):427-438. PubMed ID: 36918782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
    Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
    Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer.
    Cheng A; Guo X; Dai X; Wang Z
    FEBS Open Bio; 2021 Jun; 11(6):1785-1798. PubMed ID: 33837660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YTHDF1 regulates immune cell infiltration in gastric cancer via interaction with p53.
    Liao Q; Xiong J
    Exp Ther Med; 2024 Jun; 27(6):255. PubMed ID: 38682111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Endothelial Marker TEM7 is a Prognostic Biomarker and Correlating with Immune Infiltrates in Gastric Cancer.
    Geng L; Chen S; Gong Y; Zhou Y; Yang H; Tang L
    Int J Gen Med; 2021; 14():10155-10171. PubMed ID: 34992436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of
    Lu W; Zang R; Du Y; Li X; Li H; Liu C; Song Y; Li Y; Wang Y
    Cancer Manag Res; 2020; 12():11095-11102. PubMed ID: 33173342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.